These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28522663)

  • 21. Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS.
    Tian W; Zhu T; Zhong J; Liu X; Rao P; Segal BM; Ekholm S
    Neuroradiology; 2012 Apr; 54(4):287-97. PubMed ID: 21567135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
    Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
    Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging.
    Droogan AG; Clark CA; Werring DJ; Barker GJ; McDonald WI; Miller DH
    Magn Reson Imaging; 1999 Jun; 17(5):653-61. PubMed ID: 10372518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
    Amaral LLFD; Fragoso DC; Rocha AJD
    Arq Neuropsiquiatr; 2019 Jul; 77(7):485-492. PubMed ID: 31365640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.
    do Amaral LLF; Fragoso DC; Nunes RH; Littig IA; da Rocha AJ
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):614-619. PubMed ID: 30846435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusivity in multiple sclerosis lesions: At the cutting edge?
    Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
    Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
    Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.
    Kleesiek J; Morshuis JN; Isensee F; Deike-Hofmann K; Paech D; Kickingereder P; Köthe U; Rother C; Forsting M; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2019 Oct; 54(10):653-660. PubMed ID: 31261293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images.
    Nusbaum AO; Lu D; Tang CY; Atlas SW
    AJR Am J Roentgenol; 2000 Sep; 175(3):821-5. PubMed ID: 10954474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of "black holes".
    Lapucci C; Romano N; Schiavi S; Saitta L; Uccelli A; Boffa G; Pardini M; Signori A; Castellan L; Inglese M; Roccatagliata L
    Eur Radiol; 2020 Jul; 30(7):3843-3851. PubMed ID: 32162002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do All Patients with Multiple Sclerosis Benefit from the Use of Contrast on Serial Follow-Up MR Imaging? A Retrospective Analysis.
    Mattay RR; Davtyan K; Bilello M; Mamourian AC
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):2001-2006. PubMed ID: 30287455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of Noncontrast T2 SPACE in Active MS Cord Lesion Detection.
    Sayah A; Khayat E; Lee EC; Makariou EV
    AJNR Am J Neuroradiol; 2023 Dec; 44(12):1458-1463. PubMed ID: 38049982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weekly follow up of acute lesions in three early multiple sclerosis patients using MR spectroscopy and diffusion.
    Kocevar G; Stamile C; Hannoun S; Roch JA; Durand-Dubief F; Vukusic S; Cotton F; Sappey-Marinier D
    J Neuroradiol; 2018 Mar; 45(2):108-113. PubMed ID: 29032126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials.
    Krishnan AP; Song Z; Clayton D; Gaetano L; Jia X; de Crespigny A; Bengtsson T; Carano RAD
    Radiology; 2022 Mar; 302(3):662-673. PubMed ID: 34904871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
    Zhang Y; Gauthier SA; Gupta A; Chen W; Comunale J; Chiang GC; Zhou D; Askin G; Zhu W; Pitt D; Wang Y
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1629-35. PubMed ID: 27256856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review.
    Arm J; Ribbons K; Lechner-Scott J; Ramadan S
    J Neurol Sci; 2019 May; 400():52-71. PubMed ID: 30903860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Enhancing MS Lesions by Dynamic Texture Parameter Analysis of Dynamic Susceptibility Perfusion Imaging.
    Verma RK; Slotboom J; Locher C; Heldner MR; Weisstanner C; Abela E; Kellner-Weldon F; Zbinden M; Kamm CP; Wiest R
    Biomed Res Int; 2016; 2016():9578139. PubMed ID: 26885524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
    Rovira A; Alonso J; Cucurella G; Nos C; Tintoré M; Pedraza S; Rio J; Montalban X
    AJNR Am J Neuroradiol; 1999; 20(10):1939-45. PubMed ID: 10588122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Tourdias T; Roggerone S; Filippi M; Kanagaki M; Rovaris M; Miller DH; Petry KG; Brochet B; Pruvo JP; Radüe EW; Dousset V
    Radiology; 2012 Jul; 264(1):225-33. PubMed ID: 22723563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.